Pediatric patients aged 10 years and older with iron deficiency may now be treated with Accrufer following an expanded FDA approval.
HealthDay News — The US Food and Drug Administration (FDA) is weighing a change that could make warning labels on dietary supplements appear less often on packaging. Unlike prescription drugs, dietary ...
Thomas Münzel, from Johannes Gutenberg University in Germany, and colleagues developed an expert consensus paper to address nicotine itself as a direct cardiovascular toxin, independent of combustion ...
The AAP represents about 67,000 pediatricians nationwide. The cuts come amid ongoing disagreements over vaccines.
The new legislations hope to amend the Higher Education Act of 1965 to restore the full loan limits that were narrowed under Trump’s so-called “Big Beautiful Bill." ...
Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).
The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...
Zoliflodacin is an oral spiropyrimidinetrione antibiotic with activity against multidrug-resistant strains of Neisseria gonorrhoeae.
Retatrutide treatment resulted in significant improvements in WOMAC pain scores and body weight compared with placebo in the TRIUMPH-4 trial.
The researchers noted that integrating mental health support into liver disease treatment is a critical step toward protecting veterans from liver cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback